Abstract: Objective:To investigate the guidance of a new classification on the treatment methods selection for cystic dilation of bile duct (CDBD).
Methods:The clinical data of 213 patients with CDBD who received treatment according to the Todani 2003 classification at the Peking Union medical College Hospital from September 1968 to July 2013 were retrospectively analyzed. The CDBD was reclassified with a new classification proposed by Dong Jiahong et al, and the guidance of the new classification on the treatment methods selection for CDBD was analyzed. Patients were followed up via out patient examination and telephone interview till August 2013.
Results:Of the 213 patients, 139 were with Todani type Ⅰ CDBD (type C CDBD of the new classification); 3 were with Todani type Ⅱ CDBD (type C1 CDBD of the new classification); 1 was with Todani type Ⅲ CDBD (type E CDBD of the new classification); 52 were with Todani type Ⅳa CDBD (35 with type D1 and 17 with type D2 CDBD of the new classification); 1 was with Todani type Ⅳb CDBD (type C CDBD of the new classification); 8 were with Todani typeⅤ Ⅰ CDBD (type B CDBD of the new classification); 9 were with Todani type Ⅴ Ⅱ CDBD (type A CDBD of the new classification). Eighteen patients did not receive the surgical treatment. Of the 195 patients who received surgical treatment, patients with type C and D CDBD of the new classification took a large proportion. Patients with type C CDBD of the new classification received cystectomy, biliary cyst resection, Roux en Y cholangiojejunostomy or internal drainage. Patients with type D CDBD of the new classification received extrahepatic biliary cyst resection, Roux en Y cholangiojejunostomy. Patients with severe intrahepatic disease and with type D1 CDBD of the new classification received concomitant left hemihepatectomy or pancreaticoduodenectomy. Patients with type A1 CDBD of the new classification received right hemihepatectomy. Patients with type A2 CDBD of the new classification were cured by conservative treatment after split liver transplantation. Patients with type B1 CDBD of the new classification received left hemihepatectomy and Roux en Y cholangiojejunostomy. Patients with type B2 CDBD of the new classification received bile duct stone extraction. There was 1 patient with type E CDBD, and partial resection of the CDBD+bile duct reconstruction was carried out. Pancreatic fistula, biliary fistula, reflux cholangitis, cholangitis and anastomotic stricture were detected on 74 patients, and they were cured by conservative treatment or lithotomy. A total of 187 patients were followed up with the median time of 85 months (range, 1 432 months). One hundred of seventy five patients recovered well, and 12 patients with canceration of the bile duct died of tumor metastasis at postoperative 1 282 months.
Conclusion: This new classification simplifies the typing of extrahepatic bile duct dilation, refines the typing of intrahepatic bile duct dilation, and has better guidance for surgical treatment.